GENEVA, Oct. 15 -- OKLAHOMA MEDICAL RESEARCH FOUNDATION filed a patent application (US2026/023278) for “ADRENOMEDULLIN TO TREAT MYXOMATOUS HEART VALVE DISEASE”. With publication no. WO/2026/217945, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 38/22
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....